TIDMBII 
 
25 January 2011 
 
                       BIOCOMPATIBLES INTERNATIONAL PLC 
 
                      (the `Company' or `Biocompatibles') 
 
Exercise of options under the Biocompatibles International Group plc Executive 
  Share Options Scheme 1995 and the Biocompatibles International Performance 
                                  Share Plan 
 
Biocompatibles International plc announced on 24 January 2011 that at the first 
of the two court hearings required as part of the Scheme, the Court sanctioned 
the Scheme under Part 26 of the Companies Act 2006. 
 
As a result of the court sanction, all outstanding Options under the 1995 
Executive Scheme became exercisable and the following Directors entered into 
transactions in the Company's Ordinary shares of 21 53/94 pence each ("shares") 
by exercising the following options under the scheme: 
 
Executive Director  The Biocompatibles International Group plc Executive Share 
                    Options Scheme 1995 
 
                    No of       Exercise    Date of Grant Approved/Unapproved 
                    options     price 
 
Crispin Simon       31,250      GBP1.89       22.08.2001    Unapproved 
 
Crispin Simon       31,250      GBP1.89       22.08.2001    Unapproved Super 
 
Peter Stratford     30,000      GBP0.59       24.09.2001    Unapproved 
 
Additionally, as a result of the court sanction, all previously unvested awards 
under the Performance Share Plan have now vested in respect of all the 
Biocompatibles shares over which they subsist; and the following Directors 
entered into transactions in the Company's Ordinary shares of 21 53/94 pence 
each ("shares") by exercising the following awards under the Performance Share 
Plan: 
 
Executive Director        The Biocompatibles International Performance Share 
                          Plan 
 
                          No of shares subject to the award Date of award 
 
Crispin Simon             130,000                           20.09.2007 
 
Crispin Simon             109,000                           01.10.2008 
 
Crispin Simon             85,000                            11.09.2009 
 
Ian Ardill                75,000                            20.09.2007 
 
Ian Ardill                63,000                            01.10.2008 
 
Ian Ardill                50,000                            11.09.2009 
 
Peter Stratford           75,000                            20.09.2007 
 
Peter Stratford           63,000                            01.10.2008 
 
Peter Stratford           50,000                            11.09.2009 
 
John Sylvester            75,000                            20.09.2007 
 
John Sylvester            63,000                            01.10.2008 
 
John Sylvester            50,000                            11.09.2009 
 
Crispin Simon 
 
As a result of these exercises, Mr Simon is deemed to be interested in 667,678 
shares, representing 1.63% of the Company's issued share capital as of the date 
of this notification. 
 
Ian Ardill 
 
As a result of these exercises, Mr Ardill is deemed to be interested in 265,586 
shares, representing 0.65% of the Company's issued share capital as of the date 
of this notification. 
 
Peter Stratford 
 
As a result of these exercises, Mr Stratford is deemed to be interested in 
254,111 shares, representing 0.62% of the Company's issued share capital as of 
the date of this notification. 
 
John Sylvester 
 
As a result of these exercises, Mr Sylvester is deemed to be interested in 
223,275 shares, representing 0.54% of the Company's issued share capital as of 
the date of this notification. 
 
The above notifications are made in accordance with DTR 3.1.4R(1). 
 
                                   - ends - 
 
Contact: 
Biocompatibles                             Tel: +44 (0)1257 732645 
 
Ian Ardill, Finance Director 
 
Lygia Jones, Assistant Company Secretary 
 
Dealing Disclosure Requirements 
 
Following the announcement made on Monday, 20 September 2010 that the Company 
is in an offer period for the purposes of the Takeover Code, the Company is 
required to restate the following: 
 
Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of 
any class of relevant securities of an offeree company or of any paper offeror 
(being any offeror other than an offeror in respect of which it has been 
announced that its offer is, or is likely to be, solely in cash) must make an 
Opening Position Disclosure following the commencement of the offer period and, 
if later, following the announcement in which any paper offeror is first 
identified. An Opening Position Disclosure must contain details of the person's 
interests and short positions in, and rights to subscribe for, any relevant 
securities of each of (i) the offeree company and (ii) any paper offeror(s). An 
Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be 
made by no later than 3.30 pm (London time) on the 10th business day following 
the commencement of the offer period and, if appropriate, by no later than 3.30 
pm (London time) on the 10th business day following the announcement in which 
any paper offeror is first identified. Relevant persons who deal in the 
relevant securities of the offeree company or of a paper offeror prior to the 
deadline for making an Opening Position Disclosure must instead make a Dealing 
Disclosure. 
 
Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% 
or more of any class of relevant securities of the offeree company or of any 
paper offeror must make a Dealing Disclosure if the person deals in any 
relevant securities of the offeree company or of any paper offeror. A Dealing 
Disclosure must contain details of the dealing concerned and of the person's 
interests and short positions in, and rights to subscribe for, any relevant 
securities of each of (i) the offeree company and (ii) any paper offeror, save 
to the extent that these details have previously been disclosed under Rule 8. A 
Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no 
later than 3.30 pm (London time) on the business day following the date of the 
relevant dealing. If two or more persons act together pursuant to an agreement 
or understanding, whether formal or informal, to acquire or control an interest 
in relevant securities of an offeree company or a paper offeror, they will be 
deemed to be a single person for the purpose of Rule 8.3. 
 
Opening Position Disclosures must also be made by the offeree company and by 
any offeror and Dealing Disclosures must also be made by the offeree company, 
by any offeror and by any persons acting in concert with any of them (see Rules 
8.1, 8.2 and 8.4). 
 
Details of the offeree and offeror companies in respect of whose relevant 
securities Opening Position Disclosures and Dealing Disclosures must be made 
can be found in the Disclosure Table on the Takeover Panel's website at 
www.thetakeoverpanel.org.uk, including details of the number of relevant 
securities in issue, when the offer period commenced and when any offeror was 
first identified. If you are in any doubt as to whether you are required to 
make an Opening Position Disclosure or a Dealing Disclosure, you should contact 
the Panel's Market Surveillance Unit on +44 (0)20 7638 0129. 
 
 
 
END
Biocompatibles (LSE:BII)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Biocompatibles Charts.
Biocompatibles (LSE:BII)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Biocompatibles Charts.